Voyageur Pharmaceuticals (CVE:VM) and Sirios Resources (CVE:SOI) are both small-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.
Profitability
This table compares Voyageur Pharmaceuticals and Sirios Resources' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Voyageur Pharmaceuticals | N/A | N/A | N/A |
Sirios Resources | N/A | N/A | N/A |
Valuation and Earnings
This table compares Voyageur Pharmaceuticals and Sirios Resources' top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Voyageur Pharmaceuticals | N/A | N/A | N/A | C($0.02) | -10.63 |
Sirios Resources | N/A | N/A | N/A | C($0.02) | -6.11 |
Voyageur Pharmaceuticals is trading at a lower price-to-earnings ratio than Sirios Resources, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Voyageur Pharmaceuticals and Sirios Resources, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Voyageur Pharmaceuticals | 0 | 0 | 1 | 0 | 3.00 |
Sirios Resources | 0 | 0 | 1 | 0 | 3.00 |
Voyageur Pharmaceuticals presently has a consensus price target of C$0.39, indicating a potential upside of 129.41%. Sirios Resources has a consensus price target of C$0.41, indicating a potential upside of 272.73%. Given Sirios Resources' higher probable upside, analysts plainly believe Sirios Resources is more favorable than Voyageur Pharmaceuticals.
Summary
Sirios Resources beats Voyageur Pharmaceuticals on 2 of the 3 factors compared between the two stocks.